No results for ‘’
Chandra Bhagat Pharma Ltd
₹45
(0.78%)
Sat, 19 Sept 2026, 02:14 pm
Distribution Services
Medical Distributors
24.5KChandra Bhagat Pharma PE Ratio
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Chandra Bhagat Pharma Ltd Price to Earnings Ratio
The Chandra Bhagat Pharma Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Chandra Bhagat Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Chandra Bhagat Pharma Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Chandra Bhagat Pharma Ltd (NSE: , BSE: 542934) is currently trading at ₹45, with a market capitalization of ₹0. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Chandra Bhagat Pharma Ltd Price to Earnings Ratio is essential for fundamental analysis.
Chandra Bhagat Pharma Ltd Price to Earnings Ratio Current Value
The current Chandra Bhagat Pharma Ltd Price to Earnings Ratio stands at 0.
The Chandra Bhagat Pharma Ltd Price to Earnings Ratio remains stable, indicating consistent financial performance.
Chandra Bhagat Pharma Ltd Price to Earnings Ratio Historical Trend
The Chandra Bhagat Pharma Ltd Price to Earnings Ratio has shown the following historical trend:
The decline in Chandra Bhagat Pharma Ltd Price to Earnings Ratio indicates improving financial efficiency or better earnings growth.
What Chandra Bhagat Pharma Ltd Price to Earnings Ratio Indicates for Investors
The Chandra Bhagat Pharma Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Chandra Bhagat Pharma Ltd Price to Earnings Ratio Analysis Summary
The Chandra Bhagat Pharma Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Chandra Bhagat Pharma Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Chandra Bhagat Pharma Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.